PubMed Health⌕ Search

Biomedical subjects

Marcelo V Elizari

Publications and source records attributed to Marcelo V Elizari.

6 recordsLinked to original sources
PubMed2006

[Usefulness of pulsed Doppler tissue imaging in the early detection of diastolic myocardial abnormalities in first-degree relatives of patients with familial hypertrophic cardiomyopathy].

INTRODUCTION AND OBJECTIVES: Doppler tissue imaging (DTI) enables regional myocardial function to be assessed irrespective of preload. Our aim was to determine the usefulness of DTI in healthy relatives of patients with familial hypertrophic cardiomyopathy. PATIENTS AND METHOD: We studied 47 first-degree relatives of patients with familial hypertrophic cardiomyopathy (group GI) and 47 normal subjects (group GII). Echocardiographic studies, including DTI, were performed in both groups. DTI was used to measure myocardial velocities during systole (S'), early diastole (E') and atrial contraction (A') at the mitral annulus, septum, and tricuspid annulus. Isovolumic relaxation and contraction times were corrected for heart rate. With DTI assessment of regional diastolic myocardial function and use of the E'/A' ratio, normal (i.e., E'/A'>1) and abnormal (i.e., E'/A'<1) diastolic function could be distinguished. RESULTS: There were no abnormalities in regional diastolic function in group GII (right E'/A' 1.78 (0.58), septum E'/A' 2.03 (0.53), and left E'/A' 2.55 (0.80). However, in group GI, two subgroup could be distinguished using E'/A' ratio values: group GIa comprised 37 first-degree relatives with normal diastolic function (right E'/A' 1.8 (0.44), septum E'/A' 2.07 (0.41), and left E/A 2.35 (0.6) who did not differ significantly from control subjects, and group GIb comprised 10 first-degree relatives with abnormal right diastolic function (right E'/A' 0.70 (0.28), P<.001) but with less significant differences at the septum (1.57 (0.49), P<.01) and mitral annulus (1.85 (0.53), P<.01). CONCLUSIONS: In 10 of 47 (21.3%) first-degree relatives of patients with familial hypertrophic cardiomyopathy, DTI enabled the detection of ventricular diastolic abnormalities, which were more evident in the right ventricle. They could be a preclinical manifestation of disease.

Adolescent↗
PubMed2004

[Atypical behavior of QTc and ST-T intervals in a patient with the Brugada syndrome].

We present a 56-year-old man who was admitted to an emergency service after receiving an electric shock. The ECG showed a J point and ST segment elevation of up to 5 mm in leads V1 to V3, which normalized in 24 hours. The ajmaline test caused elevation of the J point and of the ST segment up to 12 mm in leads V1 to V3, QTc lengthening, and QTc and T wave alternans. These results denoted alterations in the duration of myocardial action potentials, a common finding in patients with Brugada syndrome and long QT syndrome.

Ajmaline↗
PubMed2003

Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance.

OBJECTIVE: The study analyzed the role of different variables that determine long-term sinus rhythm maintenance in patients with persistent atrial fibrillation who are treated with amiodarone. BACKGROUND: It has been recognized that different factors influence long-term sinus rhythm preservation after the conversion of persistent atrial fibrillation. Although the duration of the arrhythmia appears to be the most important factor, consistent information regarding the role of the mode of arrhythmia conversion (pharmacologic or electric) is still lacking. METHODS: One hundred and forty one anticoagulated patients with persistent atrial fibrillation (median duration 8 months, percentiles 25 and 75: 2-24) were treated for 4 weeks with oral amiodarone (600 mg/day). Those in whom the arrhythmia persisted underwent electric cardioversion. After restoration of normal sinus rhythm (either pharmacologic or electric), all patients received a daily dose of amiodarone (200 mg) and were followed for a median of 19 months (percentiles 25 and 75: 8-34 months). RESULTS: Sixty eight patients (48.22%) regained sinus rhythm during the initial period of amiodarone treatment with 600 mg/day (Group I) and 73 (51.78%) required electric cardioversion (Group II). During the entire follow-up, atrial fibrillation relapsed in 63 patients: 17 (25%) in Group I and 46 (63%) in Group II. Recurrences of the arrhythmia were strikingly less frequent in patients whose atrial fibrillation lasted 12 months or less (33/103, 32.3%) than in those whose atrial fibrillation lasted more than 12 months (30/38, 78.94%). In the multivariate analysis, the mode of reversion (HR, 0.37; CI, 0.21-0.65) and the duration of the arrhythmia (HR, 2.55; CI, 1.54-4.20) were the determinants for long-term sinus rhythm maintenance. Age, sex, left atrium size, left ventricle diameter, and the shortening fraction did not significantly influence the rate of arrhythmia recurrence. Among the 141 patients included in the study, 113 patients were followed for at least 1 year, and cardiac rhythm was assessed at this time. Of these, only 1 of 48 patients (2.1%) in Group I was in atrial fibrillation, in marked contrast with 18 of 65 patients (27.8%) in Group II (RR, 0.075; 95% CI, 0.01-0.54). CONCLUSIONS: In patients with persistent atrial fibrillation, long-term preservation of sinus rhythm under chronic amiodarone treatment may be anticipated when the arrhythmia lasts 12 months or less and/or its reversion is obtained pharmacologically. We may confidently assume that these two factors have a beneficial additive influence on the outcome.

Adult↗
PubMed2003

Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure.

OBJECTIVE: To assess urinary 6-sulfatoxymelatonin excretion in patients admitted to the hospital because of congestive heart failure (CHF). METHODS: Urinary 6-sulfatoxymelatonin was measured by a specific radioimmunoassay in 33 hospitalized patients with CHF and in 146 healthy ambulatory volunteers. Individuals with hepatic or renal failure were excluded from the sample. Data were analyzed by the Mann-Whitney test and regression analysis. RESULTS: 6-Sulfatoxymelatonin levels were significantly lower in CHF patients than controls (median 2.6 vs 6.02 microg, p < 0.0001). This decrease was observed regardless of beta-adrenergic blocker or benzodiazepine medication. A significant decrease in 6-sulfatoxymelatonin excretion occurred with age. There were no significant differences in urinary 6-sulfatoxymelatonin levels between chronic and acute CHF patients. CONCLUSIONS: The results suggest that circulating melatonin levels are low in patients with CHF. Such a decrease may precede aggravation of heart failure.

Adrenergic beta-Antagonists↗